The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis

BACKGROUND: Aldehyde dehydrogenase 1 (ALDH1) has been identified as a cancer stem cell marker. However, the clinical role of ALDH1 in non-small cell lung cancer (NSCLC) remains conflicting. This study was conducted to investigate the correlation of ALDH1 with NSCLC patients’ clinicopathological char...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jinru, Zhao, Yan, Zou, Qingxu, Liang, Feihai, Lin, Fengwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797672/
https://www.ncbi.nlm.nih.gov/pubmed/35117538
http://dx.doi.org/10.21037/tcr.2020.02.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797672/
https://www.ncbi.nlm.nih.gov/pubmed/35117538
http://dx.doi.org/10.21037/tcr.2020.02.09

Ejemplares similares